Avid Bioservices Valuation
| CDMODelisted Stock | USD 12.49 0.00 0.00% |
At this time, the firm appears to be overvalued. Avid Bioservices shows a prevailing Real Value of $10.3 per share. The current price of the firm is $12.49. Our model approximates the value of Avid Bioservices from analyzing the firm fundamentals such as Return On Equity of -1.16, profit margin of (1.01) %, and Current Valuation of 971.01 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Avid Bioservices' price fluctuation is very steady at this time. Calculation of the real value of Avid Bioservices is based on 3 months time horizon. Increasing Avid Bioservices' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Avid Bioservices is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avid Stock. However, Avid Bioservices' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.49 | Real 10.3 | Hype 12.49 |
The intrinsic value of Avid Bioservices' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avid Bioservices' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avid Bioservices helps investors to forecast how Avid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avid Bioservices more accurately as focusing exclusively on Avid Bioservices' fundamentals will not take into account other important factors: Avid Bioservices Total Value Analysis
Avid Bioservices is currently expected to have valuation of 971.01 M with market capitalization of 798.9 M, debt of 207.83 M, and cash on hands of 115.14 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Avid Bioservices fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
971.01 M | 798.9 M | 207.83 M | 115.14 M |
Avid Bioservices Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.41. Avid Bioservices last dividend was issued on the 10th of July 2017. The entity had 1:7 split on the 10th of July 2017. Based on the key indicators related to Avid Bioservices' liquidity, profitability, solvency, and operating efficiency, Avid Bioservices is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Avid Bioservices Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avid Bioservices has an asset utilization ratio of 41.57 percent. This suggests that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that Avid Bioservices is more efficient with each dollar of assets it utilizes for everyday operations.Avid Bioservices Ownership Allocation
The majority of Avid Bioservices outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Avid Bioservices to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Avid Bioservices. Please pay attention to any change in the institutional holdings of Avid Bioservices as this could imply that something significant has changed or is about to change at the company.Avid Bioservices Profitability Analysis
The company reported the previous year's revenue of 139.91 M. Net Loss for the year was (140.75 M) with profit before overhead, payroll, taxes, and interest of 8.93 M.About Avid Bioservices Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Avid Bioservices. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Avid Bioservices based exclusively on its fundamental and basic technical indicators. By analyzing Avid Bioservices's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Avid Bioservices's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avid Bioservices. We calculate exposure to Avid Bioservices's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avid Bioservices's related companies.Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.
Avid Bioservices Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 63.2 M | |
| Quarterly Earnings Growth Y O Y | -0.797 | |
| Forward Price Earnings | 88.4956 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |